DGKB and acute myeloid leukemia: Importantly, we show that selective inhibition of DGKA alone is ineffective in killing AML cell lines, while inhibitors with broader specificity against DGK isoforms show efficacy in reducing the viability and inducing cell cycle arrest in these cells.